Natacha Vanattou‐Saïfoudine

563 total citations
12 papers, 441 citations indexed

About

Natacha Vanattou‐Saïfoudine is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Clinical Psychology. According to data from OpenAlex, Natacha Vanattou‐Saïfoudine has authored 12 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 5 papers in Pharmacology and 3 papers in Clinical Psychology. Recurrent topics in Natacha Vanattou‐Saïfoudine's work include Cannabis and Cannabinoid Research (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Advanced Proteomics Techniques and Applications (3 papers). Natacha Vanattou‐Saïfoudine is often cited by papers focused on Cannabis and Cannabinoid Research (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Advanced Proteomics Techniques and Applications (3 papers). Natacha Vanattou‐Saïfoudine collaborates with scholars based in United Kingdom, Ireland and Netherlands. Natacha Vanattou‐Saïfoudine's co-authors include Sabine Bahn, Paul C. Guest, Daniel Martins‐de‐Souza, Andrew Harkin, Laura W. Harris, Ruth McNamara, Hassan Rahmoune, Maree J. Webster, Hassan Rahmoune and Anna Gossen and has published in prestigious journals such as Scientific Reports, British Journal of Pharmacology and Psychopharmacology.

In The Last Decade

Natacha Vanattou‐Saïfoudine

12 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natacha Vanattou‐Saïfoudine United Kingdom 9 192 149 123 103 83 12 441
Valéria de Almeida Brazil 15 96 0.5× 124 0.8× 258 2.1× 311 3.0× 35 0.4× 31 607
Sophie M. Banas France 9 65 0.3× 173 1.2× 259 2.1× 72 0.7× 32 0.4× 16 480
Takeshi Iwazaki Australia 9 46 0.2× 154 1.0× 307 2.5× 218 2.1× 19 0.2× 9 537
Sarah A. Vunck United States 10 125 0.7× 181 1.2× 96 0.8× 30 0.3× 56 0.7× 13 351
Mike Bickerdike United Kingdom 10 46 0.2× 283 1.9× 492 4.0× 109 1.1× 62 0.7× 15 741
Scott D. Gleason United States 16 93 0.5× 293 2.0× 484 3.9× 128 1.2× 52 0.6× 29 722
Abigail E. Agoglia United States 13 42 0.2× 133 0.9× 264 2.1× 24 0.2× 90 1.1× 17 433
Shawn Gouty United States 14 35 0.2× 271 1.8× 256 2.1× 35 0.3× 81 1.0× 24 565
Tushar Advani United States 7 56 0.3× 91 0.6× 276 2.2× 327 3.2× 97 1.2× 7 551
Ilinca Angelescu United Kingdom 10 96 0.5× 109 0.7× 172 1.4× 71 0.7× 22 0.3× 12 450

Countries citing papers authored by Natacha Vanattou‐Saïfoudine

Since Specialization
Citations

This map shows the geographic impact of Natacha Vanattou‐Saïfoudine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natacha Vanattou‐Saïfoudine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natacha Vanattou‐Saïfoudine more than expected).

Fields of papers citing papers by Natacha Vanattou‐Saïfoudine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natacha Vanattou‐Saïfoudine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natacha Vanattou‐Saïfoudine. The network helps show where Natacha Vanattou‐Saïfoudine may publish in the future.

Co-authorship network of co-authors of Natacha Vanattou‐Saïfoudine

This figure shows the co-authorship network connecting the top 25 collaborators of Natacha Vanattou‐Saïfoudine. A scholar is included among the top collaborators of Natacha Vanattou‐Saïfoudine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natacha Vanattou‐Saïfoudine. Natacha Vanattou‐Saïfoudine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vanattou‐Saïfoudine, Natacha, et al.. (2021). A robust model of Stimulus-Specific Adaptation validated on neuromorphic hardware. Scientific Reports. 11(1). 17904–17904. 1 indexed citations
2.
Ryan, Karen M., Éadaoin W. Griffin, Katie J. Ryan, et al.. (2016). Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats. Brain Behavior and Immunity. 56. 114–129. 7 indexed citations
3.
Krishnamurthy, Divya, Laura W. Harris, Yishai Levin, et al.. (2012). Metabolic, hormonal and stress-related molecular changes inpost-mortempituitary glands from schizophrenia subjects. The World Journal of Biological Psychiatry. 14(7). 478–489. 42 indexed citations
4.
Vanattou‐Saïfoudine, Natacha, Ruth McNamara, & Andrew Harkin. (2012). Caffeine provokes adverse interactions with 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and related psychostimulants: mechanisms and mediators. British Journal of Pharmacology. 167(5). 946–959. 46 indexed citations
5.
Martins‐de‐Souza, Daniel, Paul C. Guest, Natacha Vanattou‐Saïfoudine, Hassan Rahmoune, & Sabine Bahn. (2012). Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function. European Archives of Psychiatry and Clinical Neuroscience. 262(8). 657–666. 60 indexed citations
6.
Martins‐de‐Souza, Daniel, Paul C. Guest, Laura W. Harris, et al.. (2012). Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Translational Psychiatry. 2(3). e87–e87. 163 indexed citations
7.
Vanattou‐Saïfoudine, Natacha, Brendan Behan, & Andrew Harkin. (2011). Dopamine D1Receptor‐Mediated Intracellular Responses in the Hypothalamus after Co‐Administration of Caffeine with MDMA. Basic & Clinical Pharmacology & Toxicology. 110(3). 283–289. 6 indexed citations
8.
Guest, Paul C., Daniel Martins‐de‐Souza, Natacha Vanattou‐Saïfoudine, Laura W. Harris, & Sabine Bahn. (2011). Abnormalities in Metabolism and Hypothalamic–Pituitary–Adrenal Axis Function in Schizophrenia. International review of neurobiology. 101. 145–168. 25 indexed citations
9.
Martins‐de‐Souza, Daniel, Paul C. Guest, Natacha Vanattou‐Saïfoudine, Laura W. Harris, & Sabine Bahn. (2011). Proteomic Technologies for Biomarker Studies in Psychiatry. International review of neurobiology. 101. 65–94. 25 indexed citations
10.
Vanattou‐Saïfoudine, Natacha, Anna Gossen, & Andrew Harkin. (2010). A role for adenosine A1 receptor blockade in the ability of caffeine to promote MDMA “Ecstasy”-induced striatal dopamine release. European Journal of Pharmacology. 650(1). 220–228. 15 indexed citations
11.
Vanattou‐Saïfoudine, Natacha, Ruth McNamara, & Andrew Harkin. (2010). Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA (‘ecstasy’). Psychopharmacology. 211(1). 15–25. 18 indexed citations
12.
Vanattou‐Saïfoudine, Natacha, Ruth McNamara, & Andrew Harkin. (2010). Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)‐induced hyperthermia in rats. British Journal of Pharmacology. 160(4). 860–877. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026